Drug coating with topcoat
US6284305A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | May 18, 2000 |
| Grant date | Sep 4, 2001 |
| Priority date | — |
| Expiry date | May 18, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2420/08
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A coating and method for a coating an implantable device or prostheses are disclosed. The coating includes an undercoat of polymeric material containing an amount of biologically active material, particularly heparin, dispersed therein. The coating further includes a topcoat which covers less than the entire surface of the undercoat and wherein the topcoat comprises a polymeric material substantially free of pores and porosigens. The polymeric material of the topcoat can be a biostable, biocompatible material which provides long term non-thrombogenicity to the device portion during and after release of the biologically active material.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.